Let’s find out how shares of AIkido Pharma Inc. (AIKI) rallied after the market closed

0
2092
NXTP Stock
NXTP Stock

The stock price of AIkido Pharma Inc. (NASDAQ: AIKI) soared more than 29% in the ‎after-hours session last night after the company revealed positive results from its ‎sponsored Artificial Intelligence/Machine Learning Research program on patients suffering ‎from Pancreatic Cancer.‎

Get the hottest stocks to trade ‎every day before the market opens 100% ‎free. Click here now. 

In the US, pancreatic ductal adenocarcinoma is the third leading cancer-related cause of ‎death. PDA is on the rise, as it is significantly associated with obesity, smoking, and diabetes. ‎A significant obstacle to PDA treatment is that the majority of diagnoses are made late in ‎disease progression. The most effective therapeutic strategy is surgical resection, but it is not ‎curative and is restricted to early-stage diagnosis. While clinical trials have improved the five-‎year survival rate to 9%, less than 20% of patients survive for a year despite decades of ‎research.‎‎


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


Read More

‎It is imperative to develop ‎robust, systematic screening to identify novel, effective PDA therapeutics for the early stages ‎of the disease and after successful surgical resection to delay and prevent relapse. It is the ‎strategy of AIkido to identify better therapeutics by screening drugs in primary cell culture ‎then validating them in a mouse model of early disease progression.‎

LEAVE A REPLY

Please enter your comment!
Please enter your name here